Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026)

Alx Oncology Holdings' Prepaid Assets history spans 5 years, with the latest figure at $830000.0 for Q4 2023.

  • On a quarterly basis, Prepaid Assets fell 82.57% to $830000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $830000.0, a 82.57% decrease, with the full-year FY2023 number at $830000.0, down 82.57% from a year prior.
  • Prepaid Assets hit $830000.0 in Q4 2023 for Alx Oncology Holdings, down from $9.1 million in the prior quarter.
  • Over the last five years, Prepaid Assets for ALXO hit a ceiling of $9.1 million in Q3 2023 and a floor of $256000.0 in Q4 2019.
  • Historically, Prepaid Assets has averaged $3.6 million across 5 years, with a median of $3.4 million in 2021.
  • Biggest five-year swings in Prepaid Assets: surged 592.58% in 2020 and later tumbled 82.57% in 2023.
  • Tracing ALXO's Prepaid Assets over 5 years: stood at $256000.0 in 2019, then surged by 592.58% to $1.8 million in 2020, then skyrocketed by 89.06% to $3.4 million in 2021, then skyrocketed by 42.06% to $4.8 million in 2022, then tumbled by 82.57% to $830000.0 in 2023.
  • Business Quant data shows Prepaid Assets for ALXO at $830000.0 in Q4 2023, $9.1 million in Q3 2023, and $6.7 million in Q2 2023.